Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.

Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

Viatris' generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been ...

In a world where weight management is increasingly prioritized, appetite suppressants have gained immense popularity for ...

Native was one of the first to break away from the chemical-laden, generic-smelling formulas of traditional deodorants, putting thought into their fragrances—some even close to having scent pyramids.

Charlotte Tillett and Astrid Arnold outline the aims and implications of the new drug pricing legislation, the Health Service Medical Supplies (Costs) Act 2017. The UK’s Health Service Medical ...

This is the most recent version of the national Cancer Drugs Fund list, and replaces any earlier versions. It contains updates to the previous list, as well as new drugs and indications which have ...